%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Tommy Andersson, Anders Magnuson, Ing-Liss Bryngelsson, Ole Frøbert, Karin M. Henriksson, Nils Edvardsson, Dritan Poçi
Patients with atrial fibrillation and outcomes of cerebral infarction in those with treatment of warfarin versus no warfarin with references to CHA2DS2-VASc score, age and sex - A Swedish nationwide observational study with 48 433 patients
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 13 0 R/Annots 14 0 R/Contents 15 0 R/TrimBox[0 0 612 792]>>
endobj
14 0 obj
[16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R]
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176846.ref001)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176846.ref003)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176846.ref003)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176846.ref004)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176846.ref003)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176846.ref005)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176846.ref011)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176846.ref005)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176846.ref008)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176846.ref012)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176846.ref013)>>
endobj
27 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176846.ref013)>>
endobj
28 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176846.ref014)>>
endobj
29 0 obj
<>/Border[0 0 0]/A 30 0 R>>
endobj
30 0 obj
<>
endobj
15 0 obj
[31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R 38 0 R 39 0 R 40 0 R 41 0 R 42 0 R]
endobj
31 0 obj
<>stream
q
0.45 0.36 0.35 0.01 k
0 w
575.9997 577.8196 m
199.9998 577.8196 l
199.9998 578.3196 l
575.9997 578.3196 l
f*
0.83 0.64 0.02 0 k
305.4614 466.3559 m
310.337 466.3559 l
h
f*
315.5528 466.3559 m
320.4283 466.3559 l
h
f*
450.4252 453.3165 m
455.3008 453.3165 l
h
f*
460.5165 453.3165 m
465.3921 453.3165 l
h
f*
487.5591 427.3512 m
492.378 427.3512 l
h
f*
469.5874 401.3291 m
474.463 401.3291 l
h
f*
479.7354 401.3291 m
489.4299 401.3291 l
h
f*
464.0882 375.3071 m
468.9071 375.3071 l
h
f*
471.2882 375.3071 m
476.1071 375.3071 l
h
f*
478.4315 375.3071 m
488.126 375.3071 l
h
f*
532.0063 224.9008 m
541.7575 224.9008 l
h
f*
432.7937 198.9354 m
442.5449 198.9354 l
h
f*
447.874 198.9354 m
457.6252 198.9354 l
h
f*
0 g
1 j
1 J
9.5 0 0 9.5 200.0125 707.7543 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(and)Tj
1.8619 0 Td
(in)Tj
0.9846 0 Td
(women)Tj
3.4135 0 Td
(1.84)Tj
2.1424 0 Td
(\(0.863.94\))Tj
5.2754 0 Td
(while,)Tj
2.7392 0 Td
(in)Tj
0.9846 0 Td
(women)Tj
3.4135 0 Td
(with)Tj
1.9753 0 Td
(at)Tj
1.0503 0 Td
(least)Tj
2.3035 0 Td
(3)Tj
0.7699 0 Td
(points,)Tj
3.133 0 Td
(HR)Tj
1.653 0 Td
(was)Tj
1.9753 0 Td
(0.31)Tj
2.1484 0 Td
(\(0.16)Tj
-35.8238 -1.474 Td
(0.59\).)Tj
2.751 0 Td
(In)Tj
1.0444 0 Td
(patients)Tj
3.682 0 Td
(6574)Tj
2.9659 0 Td
(years)Tj
2.6378 0 Td
(and)Tj
1.8678 0 Td
(2)Tj
0.7639 0 Td
(points,)Tj
3.133 0 Td
(HR)Tj
1.653 0 Td
(in)Tj
0.9847 0 Td
(men)Tj
2.1484 0 Td
(was)Tj
1.9812 0 Td
(0.37)Tj
2.1424 0 Td
(\(0.230.59\))Tj
5.2754 0 Td
(and)Tj
1.8679 0 Td
(in)Tj
0.9787 0 Td
(women)Tj
-35.8775 -1.474 Td
(0.39)Tj
2.1423 0 Td
(\(0.210.73\).)Tj
5.55 0 Td
(Categories)Tj
5.0009 0 Td
(including)Tj
4.1057 0 Td
(age)Tj
/F6 1 Tf
0 Tc
1.8619 0 Td
()Tj
/F0 1 Tf
-0.0042 Tc
(65)Tj
2.0947 0 Td
(years)Tj
2.6377 0 Td
(or)Tj
/F6 1 Tf
0 Tc
1.098 0 Td
()Tj
/F0 1 Tf
-0.0042 Tc
(3)Tj
1.5397 0 Td
(points)Tj
2.8585 0 Td
(showed)Tj
3.6223 0 Td
(a)Tj
0.7699 0 Td
(statistically)Tj
-33.2816 -1.474 Td
(significant)Tj
4.607 0 Td
(protection)Tj
4.5593 0 Td
(from)Tj
2.208 0 Td
(warfarin.)Tj
ET
Q
q
1 j
1 J
0 w
11.4998 0 0 11.4998 200.0125 636.3212 cm
BT
/F2 1 Tf
1 TL
-0.0035 Tc
0 0 Td
(Conclusions)Tj
ET
Q
q
1 j
1 J
0 w
9.5 0 0 9.5 200.0125 619.3133 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(Our)Tj
1.8738 0 Td
(results)Tj
3.133 0 Td
(support)Tj
3.5209 0 Td
(that)Tj
1.8739 0 Td
(treatment)Tj
4.4041 0 Td
(with)Tj
1.9753 0 Td
(anticoagulation)Tj
6.8568 0 Td
(may)Tj
2.0947 0 Td
(be)Tj
1.3188 0 Td
(considered)Tj
5.0487 0 Td
(in)Tj
0.9846 0 Td
(all)Tj
1.1995 0 Td
(patients)Tj
-34.2841 -1.474 Td
(with)Tj
1.9752 0 Td
(an)Tj
1.3189 0 Td
(incident)Tj
3.6164 0 Td
(atrial)Tj
2.3572 0 Td
(fibrillation)Tj
4.3743 0 Td
(diagnosis)Tj
4.3862 0 Td
(and)Tj
1.8619 0 Td
(an)Tj
1.3189 0 Td
(age)Tj
1.8679 0 Td
(of)Tj
1.0443 0 Td
(65)Tj
1.3189 0 Td
(years)Tj
2.6377 0 Td
(and)Tj
1.8678 0 Td
(older,)Tj
2.6855 0 Td
(i.e.)Tj
1.5396 0 Td
(also)Tj
2.029 0 Td
(when)Tj
-36.1997 -1.474 Td
(the)Tj
1.5933 0 Td
(CHA)Tj
ET
Q
q
1 j
1 J
0 w
7.1248 0 0 6.3325 235.0488 589.7196 cm
BT
/F0 1 Tf
1 TL
-0.0056 Tc
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0 w
9.5 0 0 9.5 238.9606 591.307 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(DS)Tj
ET
Q
q
1 j
1 J
0 w
7.1248 0 0 6.3325 252.0566 589.7196 cm
BT
/F0 1 Tf
1 TL
-0.0056 Tc
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0 w
9.5 0 0 9.5 255.9118 591.307 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(-VASc)Tj
3.0375 0 Td
(score)Tj
2.6437 0 Td
(is)Tj
0.9309 0 Td
(1.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 523.3889 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 506.3811 cm
BT
/F8 1 Tf
1 TL
0.005 Tc
0 0 Td
(Treatment)Tj
4.5297 0 Td
(with)Tj
2.0296 0 Td
(an)Tj
1.2245 0 Td
(anticoagulant)Tj
5.7657 0 Td
(in)Tj
1.0545 0 Td
(patients)Tj
3.4412 0 Td
(with)Tj
2.0353 0 Td
(atrial)Tj
2.3243 0 Td
(fibrillation)Tj
4.5751 0 Td
(\(AF\))Tj
2.1487 0 Td
(decreases)Tj
4.0478 0 Td
(the)Tj
1.4967 0 Td
(risk)Tj
1.7518 0 Td
(of)Tj
-36.4249 -1.2982 Td
(cerebral)Tj
3.4922 0 Td
(infarction;)Tj
4.4957 0 Td
(the)Tj
1.4967 0 Td
(challenge)Tj
4.0422 0 Td
(consists)Tj
3.4186 0 Td
(of)Tj
1.0318 0 Td
(balancing)Tj
4.1725 0 Td
(between)Tj
3.5943 0 Td
(protection)Tj
4.4674 0 Td
(against)Tj
3.0954 0 Td
(thrombo-)Tj
-33.3068 -1.2983 Td
(embolic)Tj
3.4752 0 Td
(diseases)Tj
3.4526 0 Td
(and)Tj
1.7574 0 Td
(complications)Tj
5.9528 0 Td
(of)Tj
1.0374 0 Td
(bleeding,)Tj
3.9345 0 Td
(and)Tj
1.7575 0 Td
(risk)Tj
1.7518 0 Td
(scores)Tj
2.7212 0 Td
(have)Tj
2.092 0 Td
(been)Tj
2.16 0 Td
(under)Tj
2.6645 0 Td
(develop-)Tj
-32.7569 -1.2982 Td
(ment)Tj
2.347 0 Td
(for)Tj
1.4117 0 Td
(almost)Tj
2.9366 0 Td
(20)Tj
1.1906 0 Td
(years)Tj
2.313 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(].)Tj
2.6476 0 Td
(Guidelines)Tj
4.6148 0 Td
(recommend)Tj
5.1646 0 Td
(the)Tj
1.4967 0 Td
(CHA)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 462.6708 465.7322 cm
BT
/F8 1 Tf
1 TL
0.0067 Tc
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 466.2992 467.433 cm
BT
/F8 1 Tf
1 TL
0.005 Tc
0 0 Td
(DS)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 478.6015 465.7322 cm
BT
/F8 1 Tf
1 TL
0.0067 Tc
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 482.2866 467.433 cm
BT
/F8 1 Tf
1 TL
0.005 Tc
0 0 Td
(-VASc)Tj
2.8913 0 Td
(score,)Tj
2.5852 0 Td
(which)Tj
2.6928 0 Td
(is)Tj
-36.3965 -1.3039 Td
(the)Tj
1.4967 0 Td
(most)Tj
2.2394 0 Td
(commonly)Tj
4.6204 0 Td
(used)Tj
2.092 0 Td
(risk)Tj
1.7518 0 Td
(score)Tj
2.3527 0 Td
(in)Tj
1.0545 0 Td
(clinical)Tj
3.1464 0 Td
(practice)Tj
3.4526 0 Td
(today)Tj
2.4888 0 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(].)Tj
2.6475 0 Td
(According)Tj
4.5183 0 Td
(to)Tj
1.0432 0 Td
(the)Tj
-32.9043 -1.2982 Td
(CHA)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 221.4425 439.7669 cm
BT
/F8 1 Tf
1 TL
0.0067 Tc
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 225.0708 441.411 cm
BT
/F8 1 Tf
1 TL
0.005 Tc
0 0 Td
(DS)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 237.3732 439.7669 cm
BT
/F8 1 Tf
1 TL
0.0067 Tc
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 241.0015 441.411 cm
BT
/F8 1 Tf
1 TL
0.005 Tc
0 0 Td
(-VASc)Tj
2.8969 0 Td
(score,)Tj
2.5852 0 Td
(anticoagulant)Tj
5.7657 0 Td
(therapy)Tj
3.3108 0 Td
(is)Tj
0.8674 0 Td
(recommended)Tj
6.1341 0 Td
(or)Tj
1.1169 0 Td
(considered)Tj
4.6884 0 Td
(for)Tj
1.4117 0 Td
(patients)Tj
-32.8759 -1.2982 Td
(with)Tj
2.0296 0 Td
(2)Tj
0.7086 0 Td
(or)Tj
1.1169 0 Td
(more)Tj
2.3753 0 Td
(points)Tj
2.7723 0 Td
(while)Tj
2.4151 0 Td
(those)Tj
2.381 0 Td
(with)Tj
2.0353 0 Td
(a)Tj
0.6633 0 Td
(0)Tj
0.703 0 Td
(point)Tj
2.4038 0 Td
(should)Tj
2.9707 0 Td
(not)Tj
1.5987 0 Td
(be)Tj
1.1679 0 Td
(treated)Tj
3.0613 0 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(].)Tj
1.6385 0 Td
(However,)Tj
4.1499 0 Td
(the)Tj
1.4966 0 Td
(1)Tj
-35.6878 -1.3039 Td
(point)Tj
2.4037 0 Td
(group)Tj
2.6532 0 Td
(constitutes)Tj
4.6317 0 Td
(a)Tj
0.6633 0 Td
(gray)Tj
1.9786 0 Td
(zone)Tj
2.1487 0 Td
(with)Tj
2.0352 0 Td
(a)Tj
0.6633 0 Td
(reported)Tj
3.7304 0 Td
(annual)Tj
3.016 0 Td
(incidence)Tj
4.1499 0 Td
(of)Tj
1.0318 0 Td
(stroke)Tj
2.7326 0 Td
(and)Tj
1.7575 0 Td
(transient)Tj
-33.5959 -1.2983 Td
(ischemic)Tj
3.804 0 Td
(attack)Tj
2.6588 0 Td
(\(TIA\))Tj
2.5795 0 Td
(between)Tj
3.5943 0 Td
(0.2%)Tj
2.1884 0 Td
(and)Tj
1.7575 0 Td
(6.6%)Tj
2.1883 0 Td
(in)Tj
1.0545 0 Td
(different)Tj
3.736 0 Td
(studies)Tj
3.0501 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(].)Tj
3.1294 0 Td
(Some)Tj
2.4831 0 Td
(studies)Tj
3.0501 0 Td
(have)Tj
-35.274 -1.2983 Td
(indicated)Tj
4.0195 0 Td
(that,)Tj
2.0465 0 Td
(among)Tj
3.0387 0 Td
(patients)Tj
3.4412 0 Td
(with)Tj
2.0296 0 Td
(AF)Tj
1.4514 0 Td
(and)Tj
1.7574 0 Td
(1)Tj
0.703 0 Td
(point)Tj
2.4038 0 Td
(in)Tj
1.0545 0 Td
(the)Tj
1.4967 0 Td
(CHA)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 455.8677 387.7228 cm
BT
/F8 1 Tf
1 TL
0.0067 Tc
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 459.496 389.4236 cm
BT
/F8 1 Tf
1 TL
0.005 Tc
0 0 Td
(DS)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 471.7984 387.7228 cm
BT
/F8 1 Tf
1 TL
0.0067 Tc
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 475.4834 389.4236 cm
BT
/F8 1 Tf
1 TL
0.005 Tc
0 0 Td
(-VASc)Tj
2.8913 0 Td
(score,)Tj
2.5852 0 Td
(an)Tj
1.2188 0 Td
(age)Tj
-34.2422 -1.3039 Td
(between)Tj
3.5887 0 Td
(65)Tj
1.1905 0 Td
(and)Tj
1.7575 0 Td
(74)Tj
1.1905 0 Td
(years)Tj
2.3074 0 Td
(is)Tj
0.8674 0 Td
(at)Tj
0.9695 0 Td
(the)Tj
1.4966 0 Td
(highest)Tj
3.1521 0 Td
(risk)Tj
1.7518 0 Td
(for)Tj
1.4117 0 Td
(stroke)Tj
2.7326 0 Td
(and)Tj
1.7574 0 Td
(TIA)Tj
1.8822 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
(].)Tj
3.5602 0 Td
(Our)Tj
1.8936 0 Td
(aim)Tj
1.7688 0 Td
(was,)Tj
1.9615 0 Td
(in)Tj
1.0488 0 Td
(a)Tj
-36.2888 -1.2982 Td
(nationwide)Tj
4.8132 0 Td
(cohort)Tj
2.9084 0 Td
(of)Tj
1.0318 0 Td
(patients)Tj
3.4412 0 Td
(with)Tj
2.0353 0 Td
(incident)Tj
3.5943 0 Td
(AF)Tj
1.4513 0 Td
(with)Tj
2.0353 0 Td
(and)Tj
1.7574 0 Td
(without)Tj
3.3903 0 Td
(warfarin)Tj
3.6905 0 Td
(therapy,)Tj
3.5433 0 Td
(to)Tj
1.0432 0 Td
(com-)Tj
-34.7355 -1.2983 Td
(pare)Tj
2.0013 0 Td
(the)Tj
1.4967 0 Td
(risks)Tj
2.1203 0 Td
(of)Tj
1.0318 0 Td
(cerebral)Tj
3.4922 0 Td
(infarction)Tj
4.2633 0 Td
(and)Tj
1.7575 0 Td
(stroke)Tj
2.7326 0 Td
(according)Tj
4.2689 0 Td
(to)Tj
1.0432 0 Td
(CHA)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 463.5212 348.7181 cm
BT
/F8 1 Tf
1 TL
0.0067 Tc
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 467.1496 350.4188 cm
BT
/F8 1 Tf
1 TL
0.005 Tc
0 0 Td
(DS)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 479.4519 348.7181 cm
BT
/F8 1 Tf
1 TL
0.0067 Tc
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 483.0803 350.4188 cm
BT
/F8 1 Tf
1 TL
0.005 Tc
0 0 Td
(-VASc)Tj
2.8969 0 Td
(score,)Tj
2.5852 0 Td
(age)Tj
1.5704 0 Td
(and)Tj
-35.359 -1.2982 Td
(sex.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 308.0125 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Materials)Tj
4.5071 0 Td
(and)Tj
1.989 0 Td
(methods)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 291.0047 cm
BT
/F8 1 Tf
1 TL
0.009 Tc
0 0 Td
(We)Tj
1.6327 0 Td
(conducted)Tj
4.5467 0 Td
(a)Tj
0.6633 0 Td
(nationwide,)Tj
5.0967 0 Td
(retrospective)Tj
5.5275 0 Td
(cohort)Tj
2.9367 0 Td
(study)Tj
2.4548 0 Td
(using)Tj
2.4548 0 Td
(the)Tj
1.508 0 Td
(Swedish)Tj
3.5773 0 Td
(National)Tj
3.7927 0 Td
(Patient)Tj
-34.1912 -1.2982 Td
(Registry,)Tj
3.8267 0 Td
(the)Tj
1.508 0 Td
(National)Tj
3.7928 0 Td
(Prescribed)Tj
4.5864 0 Td
(Drugs)Tj
2.7439 0 Td
(Registry,)Tj
3.8267 0 Td
(the)Tj
1.5081 0 Td
(Swedish)Tj
3.5773 0 Td
(Register)Tj
3.5546 0 Td
(of)Tj
1.0431 0 Td
(Education)Tj
4.4391 0 Td
(and)Tj
1.7688 0 Td
(the)Tj
-36.1755 -1.3039 Td
(Population)Tj
4.7621 0 Td
(and)Tj
1.7688 0 Td
(Housing)Tj
3.7531 0 Td
(Census)Tj
3.1861 0 Td
(Registry,)Tj
3.8211 0 Td
(and)Tj
1.7745 0 Td
(the)Tj
1.508 0 Td
(study)Tj
2.4548 0 Td
(cohort)Tj
2.931 0 Td
(was)Tj
1.7348 0 Td
(identified)Tj
4.1895 0 Td
(by)Tj
1.2076 0 Td
(the)Tj
1.508 0 Td
(epide-)Tj
-34.5994 -1.2983 Td
(miological)Tj
4.5297 0 Td
(centre)Tj
2.7893 0 Td
(at)Tj
0.9751 0 Td
(the)Tj
1.5137 0 Td
(Swedish)Tj
3.5773 0 Td
(National)Tj
3.7927 0 Td
(Board)Tj
2.7042 0 Td
(of)Tj
1.0432 0 Td
(Health)Tj
2.9933 0 Td
(and)Tj
1.7688 0 Td
(Welfare)Tj
3.464 0 Td
(and)Tj
1.7688 0 Td
(Statistics)Tj
3.8381 0 Td
(Swe-)Tj
-34.7582 -1.2983 Td
(den.)Tj
1.9955 0 Td
(The)Tj
1.8199 0 Td
(Swedish)Tj
3.5773 0 Td
(National)Tj
3.7984 0 Td
(Patient)Tj
3.1407 0 Td
(Registry)Tj
3.583 0 Td
(has)Tj
1.5817 0 Td
(a)Tj
/F12 1 Tf
0 Tc
0.669 0 Td
(>)Tj
/F8 1 Tf
0.009 Tc
(99%)Tj
2.7382 0 Td
(coverage)Tj
3.8268 0 Td
(of)Tj
1.0431 0 Td
(hospital)Tj
3.481 0 Td
(diagnoses)Tj
4.2349 0 Td
(from)Tj
-35.4895 -1.3039 Td
(1987)Tj
2.1713 0 Td
(and)Tj
1.7688 0 Td
(onwards,)Tj
3.9855 0 Td
(and)Tj
1.7688 0 Td
(the)Tj
1.508 0 Td
(diagnoses)Tj
4.2349 0 Td
(have)Tj
2.109 0 Td
(a)Tj
0.669 0 Td
(positive)Tj
3.4185 0 Td
(predictive)Tj
4.3257 0 Td
(value)Tj
2.3697 0 Td
(of)Tj
1.0432 0 Td
(8595%)Tj
3.4752 0 Td
([)Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
(].)Tj
2.1373 0 Td
(The)Tj
-34.9849 -1.2982 Td
(validity)Tj
3.2711 0 Td
(of)Tj
1.0432 0 Td
(the)Tj
1.508 0 Td
(registry)Tj
3.3392 0 Td
(is)Tj
0.873 0 Td
(high)Tj
2.058 0 Td
(and)Tj
1.7688 0 Td
(has)Tj
1.5817 0 Td
(therefore)Tj
3.9742 0 Td
(been)Tj
2.1713 0 Td
(recommended)Tj
6.1795 0 Td
(for)Tj
1.4229 0 Td
(use)Tj
1.5761 0 Td
(in)Tj
1.0602 0 Td
(epidemiologi-)Tj
-31.8272 -1.2983 Td
(cal)Tj
1.3606 0 Td
(studies)Tj
3.0784 0 Td
(by)Tj
1.2075 0 Td
(the)Tj
1.5081 0 Td
(National)Tj
3.7984 0 Td
(Board)Tj
2.7042 0 Td
(of)Tj
1.0375 0 Td
(Health)Tj
2.999 0 Td
(and)Tj
1.7688 0 Td
(Welfare)Tj
3.4639 0 Td
([)Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(14)Tj
0 g
(].)Tj
3.6454 0 Td
(Information)Tj
5.295 0 Td
(about)Tj
2.5569 0 Td
(medi-)Tj
-34.4237 -1.3039 Td
(cation)Tj
2.7779 0 Td
(was)Tj
1.7348 0 Td
(obtained)Tj
3.8381 0 Td
(from)Tj
2.2563 0 Td
(the)Tj
1.508 0 Td
(National)Tj
3.7985 0 Td
(Prescribed)Tj
4.5864 0 Td
(Drugs)Tj
2.7439 0 Td
(Registry,)Tj
3.8267 0 Td
(which)Tj
2.7156 0 Td
(started)Tj
3.0217 0 Td
(1)Tj
0.7087 0 Td
(July)Tj
1.8312 0 Td
(2005.)Tj
-35.3478 -1.2983 Td
(To)Tj
1.3606 0 Td
(increase)Tj
3.5773 0 Td
(the)Tj
1.508 0 Td
(probability)Tj
4.7395 0 Td
(that)Tj
1.8312 0 Td
(patients)Tj
3.4752 0 Td
(did)Tj
1.5817 0 Td
(not)Tj
1.6101 0 Td
(take)Tj
1.9276 0 Td
(warfarin)Tj
3.719 0 Td
(before)Tj
2.8176 0 Td
(the)Tj
1.508 0 Td
(study)Tj
2.4548 0 Td
(period)Tj
-32.1106 -1.2983 Td
(began,)Tj
2.9026 0 Td
(we)Tj
1.3493 0 Td
(applied)Tj
3.2485 0 Td
(a)Tj
0.6633 0 Td
(washout)Tj
3.651 0 Td
(period)Tj
2.914 0 Td
(between)Tj
3.617 0 Td
(1)Tj
0.7086 0 Td
(July)Tj
1.8312 0 Td
(2005)Tj
2.177 0 Td
(and)Tj
1.7688 0 Td
(six)Tj
1.3493 0 Td
(months)Tj
3.3618 0 Td
(afterwards.)Tj
4.7849 0 Td
(Thus,)Tj
-34.3273 -1.2982 Td
(patients)Tj
3.4695 0 Td
(with)Tj
2.0523 0 Td
(incident)Tj
3.6283 0 Td
(AF)Tj
1.457 0 Td
(between)Tj
3.617 0 Td
(1)Tj
0.7087 0 Td
(January)Tj
3.4129 0 Td
(2006)Tj
2.177 0 Td
(and)Tj
1.7688 0 Td
(31)Tj
1.1962 0 Td
(December)Tj
4.4503 0 Td
(2008)Tj
2.177 0 Td
(were)Tj
2.1714 0 Td
(eligible.)Tj
3.4129 0 Td
(AF)Tj
-35.6993 -1.3039 Td
(was)Tj
1.7347 0 Td
(defined)Tj
3.3166 0 Td
(according)Tj
4.3086 0 Td
(to)Tj
1.0488 0 Td
(the)Tj
1.508 0 Td
(International)Tj
5.6579 0 Td
(Classification)Tj
5.7657 0 Td
(of)Tj
1.0431 0 Td
(Diseases)Tj
3.6907 0 Td
(\(ICD\):)Tj
2.9423 0 Td
(427)Tj
1.6838 0 Td
(D)Tj
0.9695 0 Td
(\(DA,)Tj
2.262 0 Td
(DB,)Tj
-35.9317 -1.2983 Td
(DC,)Tj
1.8821 0 Td
(DD,)Tj
1.9559 0 Td
(DW\))Tj
2.3018 0 Td
(in)Tj
1.0601 0 Td
(ICD)Tj
2.0013 0 Td
(9)Tj
0.7086 0 Td
(\(19871996\))Tj
5.3631 0 Td
(and)Tj
1.7688 0 Td
(I)Tj
0.5783 0 Td
(48,)Tj
1.4343 0 Td
(I48.9)Tj
2.2791 0 Td
(and)Tj
1.7688 0 Td
(I)Tj
0.5726 0 Td
(48.9)Tj
1.9218 0 Td
(\(A,)Tj
1.5081 0 Td
(B,)Tj
1.0544 0 Td
(C,)Tj
1.1339 0 Td
(D,)Tj
1.2075 0 Td
(E,)Tj
1.0375 0 Td
(F,)Tj
1.0035 0 Td
(P,)Tj
1.0261 0 Td
(X\))Tj
1.2416 0 Td
(in)Tj
-34.8092 -1.2983 Td
(ICD)Tj
1.9955 0 Td
(10)Tj
1.2019 0 Td
(\(1997-\).)Tj
3.4809 0 Td
(According)Tj
4.5524 0 Td
(to)Tj
1.0545 0 Td
(the)Tj
1.508 0 Td
(CHA)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 359.4897 107.3196 cm
BT
/F8 1 Tf
1 TL
0.012 Tc
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 363.1748 109.0204 cm
BT
/F8 1 Tf
1 TL
0.009 Tc
0 0 Td
(DS)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 375.5338 107.3196 cm
BT
/F8 1 Tf
1 TL
0.012 Tc
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 379.2188 109.0204 cm
BT
/F8 1 Tf
1 TL
0.009 Tc
0 0 Td
(-VASc)Tj
2.9139 0 Td
(score,)Tj
2.6079 0 Td
(patients)Tj
3.4753 0 Td
(could)Tj
2.5171 0 Td
(receive)Tj
3.0954 0 Td
(a)Tj
0.669 0 Td
(maximum)Tj
-33.1991 -1.3039 Td
(of)Tj
1.0375 0 Td
(9)Tj
0.7087 0 Td
(points:)Tj
3.0387 0 Td
(age)Tj
1.5817 0 Td
(65)Tj
1.1962 0 Td
(to)Tj
1.0488 0 Td
(74)Tj
1.2019 0 Td
(years)Tj
2.3301 0 Td
(\(1)Tj
1.0601 0 Td
(point\))Tj
2.778 0 Td
(and)Tj
/F6 1 Tf
0 Tc
1.7688 0 Td
()Tj
/F8 1 Tf
0.009 Tc
(75)Tj
1.9671 0 Td
(years)Tj
2.3301 0 Td
(\(2)Tj
1.0601 0 Td
(points\),)Tj
3.3902 0 Td
(female)Tj
2.931 0 Td
(sex)Tj
1.5081 0 Td
(\(1)Tj
1.0658 0 Td
(point\))Tj
2.7722 0 Td
(and)Tj
-34.7751 -1.2982 Td
(diagnoses)Tj
4.2293 0 Td
(from)Tj
2.262 0 Td
(ICD)Tj
1.9956 0 Td
(9)Tj
0.7087 0 Td
(and)Tj
1.7688 0 Td
(ICD)Tj
2.0012 0 Td
(10:)Tj
1.4343 0 Td
(congestive)Tj
4.524 0 Td
(heart)Tj
2.3357 0 Td
(failure)Tj
2.8687 0 Td
(428)Tj
1.6894 0 Td
(and)Tj
1.7688 0 Td
(I)Tj
0.5726 0 Td
(50)Tj
1.1962 0 Td
(\(1)Tj
1.0602 0 Td
(point\),)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 259.0866 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Atrial)Tj
2.459 0 Td
(fibrillation)Tj
4.3442 0 Td
(and)Tj
1.8567 0 Td
(an)Tj
1.3039 0 Td
(age)Tj
1.8567 0 Td
(of)Tj
1.0418 0 Td
(65)Tj
1.311 0 Td
(years)Tj
2.6291 0 Td
(and)Tj
1.8497 0 Td
(older)Tj
2.4023 0 Td
(-)Tj
0.5457 0 Td
(Enough)Tj
3.6071 0 Td
(to)Tj
1.0418 0 Td
(justify)Tj
2.7283 0 Td
(anticoagu)Tj
4.252 0 Td
(lation)Tj
2.5583 0 Td
(therapy?)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01768)Tj
4.089 0 Td
(46)Tj
0 g
2.0906 0 Td
(May)Tj
2.0906 0 Td
(4,)Tj
1.0346 0 Td
(2017)Tj
35.7806 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(17)Tj
/F10 1 Tf
-0.025 Tc
-66.402 84.0904 Td
(data)Tj
1.7929 0 Td
(collection)Tj
3.7347 0 Td
(and)Tj
1.5945 0 Td
(analysis)Tj
2.9622 0 Td
(,)Tj
0.4464 0 Td
(decision)Tj
3.2883 0 Td
(to)Tj
0.9496 0 Td
(publish,)Tj
3.1465 0 Td
(or)Tj
-17.9151 -1.3748 Td
(preparation)Tj
4.4433 0 Td
(of)Tj
0.9496 0 Td
(the)Tj
1.3677 0 Td
(manuscript.)Tj
4.6347 0 Td
(The)Tj
1.5945 0 Td
(specific)Tj
3.0189 0 Td
(roles)Tj
2.0339 0 Td
(of)Tj
-18.0426 -1.3749 Td
(the)Tj
1.3677 0 Td
(authors)Tj
3.0472 0 Td
(are)Tj
1.3678 0 Td
(articulated)Tj
4.0606 0 Td
(in)Tj
0.8859 0 Td
(the)Tj
1.3677 0 Td
(author)Tj
-12.0969 -1.3748 Td
(contributio)Tj
3.9897 0 Td
(n)Tj
0.6945 0 Td
(section.)Tj
/F9 1 Tf
-4.6842 -2.126 Td
(Competing)Tj
4.3795 0 Td
(interests)Tj
3.3307 0 Td
(:)Tj
/F10 1 Tf
0.4819 0 Td
(I)Tj
0.4748 0 Td
(have)Tj
1.956 0 Td
(read)Tj
1.8425 0 Td
(the)Tj
1.3677 0 Td
(journal's)Tj
-13.8331 -1.3748 Td
(policy)Tj
2.3952 0 Td
(and)Tj
1.5875 0 Td
(the)Tj
1.3748 0 Td
(authors)Tj
3.0402 0 Td
(of)Tj
0.9496 0 Td
(this)Tj
1.5661 0 Td
(manuscript)Tj
4.415 0 Td
(have)Tj
1.9559 0 Td
(the)Tj
-17.2843 -1.3748 Td
(following)Tj
3.5858 0 Td
(competing)Tj
4.1599 0 Td
(interests:)Tj
3.6142 0 Td
(KMH)Tj
2.0905 0 Td
(is)Tj
0.8292 0 Td
(a)Tj
0.6449 0 Td
(former)Tj
-14.9245 -1.3748 Td
(employee)Tj
3.7984 0 Td
(of)Tj
0.9496 0 Td
(AstraZeneca)Tj
4.7835 0 Td
(R&D.)Tj
2.2607 0 Td
(This)Tj
1.7787 0 Td
(does)Tj
2.0126 0 Td
(not)Tj
1.4174 0 Td
(alter)Tj
-17.0009 -1.3748 Td
(our)Tj
1.474 0 Td
(adherence)Tj
4.0536 0 Td
(to)Tj
0.9496 0 Td
(PLOS)Tj
2.3315 0 Td
(ONE)Tj
1.8709 0 Td
(policies)Tj
3.0118 0 Td
(on)Tj
1.1622 0 Td
(sharing)Tj
-14.8536 -1.3748 Td
(data)Tj
1.7929 0 Td
(and)Tj
1.5874 0 Td
(materials.)Tj
3.8339 0 Td
(The)Tj
1.5874 0 Td
(other)Tj
2.1473 0 Td
(authors)Tj
3.0472 0 Td
(have)Tj
-13.9961 -1.3749 Td
(declared)Tj
3.3519 0 Td
(that)Tj
1.63 0 Td
(no)Tj
1.1622 0 Td
(competing)Tj
4.1599 0 Td
(interests)Tj
ET
endstream
endobj
32 0 obj
<>stream
endstream
endobj
33 0 obj
<>stream
endstream
endobj
34 0 obj
<>stream
endstream
endobj
35 0 obj
<>stream
endstream
endobj
36 0 obj
<>stream
endstream
endobj
37 0 obj
<>stream
endstream
endobj
38 0 obj
<>stream
endstream
endobj
39 0 obj
<>stream
endstream
endobj
40 0 obj
<>stream
endstream
endobj
41 0 obj
<>stream
endstream
endobj
42 0 obj
<>stream
BT
13.6914 69.591 Td
(exist.)Tj
ET
Q
endstream
endobj
43 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 13 0 R/Annots 44 0 R/Contents 45 0 R/TrimBox[0 0 612 792]>>
endobj
44 0 obj
[46 0 R 47 0 R 48 0 R 49 0 R 50 0 R 51 0 R 52 0 R 53 0 R 54 0 R 55 0 R]
endobj
46 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176846.ref005)>>
endobj
47 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176846.ref001)>>
endobj
48 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176846.ref003)>>
endobj
49 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176846.ref015)>>
endobj
50 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176846.ref016)>>
endobj
51 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176846.g001)>>
endobj
52 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176846.t001)>>
endobj
53 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176846.ref017)>>
endobj
54 0 obj
<>/Border[0 0 0]/Dest(Rpone.0176846.t002)>>
endobj
55 0 obj
<>/Border[0 0 0]/A 56 0 R>>
endobj
56 0 obj
<>
endobj
45 0 obj
[57 0 R 58 0 R 59 0 R 60 0 R 61 0 R 62 0 R 63 0 R 64 0 R 65 0 R 66 0 R 67 0 R 68 0 R]
endobj
57 0 obj
<>stream
q
0.83 0.64 0.02 0 k
370.5449 615.3449 m
375.2504 615.3449 l
h
f*
563.4709 602.3055 m
568.2331 602.3055 l
h
f*
203.4142 563.3008 m
208.1764 563.3008 l
h
f*
210.3874 563.3008 m
219.9118 563.3008 l
h
f*
222.1795 563.3008 m
231.7039 563.3008 l
h
f*
239.8677 411.5906 m
259.4268 411.5906 l
h
f*
203.4142 346.5638 m
232.5543 346.5638 l
h
f*
246.1606 307.5591 m
255.685 307.5591 l
h
f*
242.1921 168.8315 m
271.389 168.8315 l
h
f*
0 g
1 j
1 J
0 w
10 0 0 10 200.0125 707.4141 cm
BT
/F8 1 Tf
1 TL
0.009 Tc
0 0 Td
(hypertension)Tj
5.6239 0 Td
(401405)Tj
3.6793 0 Td
(and)Tj
1.7745 0 Td
(I)Tj
0.5726 0 Td
(1014)Tj
2.7042 0 Td
(\(1)Tj
1.0602 0 Td
(point\),)Tj
3.016 0 Td
(diabetes)Tj
3.566 0 Td
(mellitus)Tj
3.5149 0 Td
(250)Tj
1.6838 0 Td
(and)Tj
1.7688 0 Td
(E)Tj
0.805 0 Td
(1014)Tj
2.7042 0 Td
(\(1)Tj
1.0602 0 Td
(point\),)Tj
-33.5336 -1.3039 Td
(cerebral)Tj
3.5206 0 Td
(infarction)Tj
4.3086 0 Td
(433434)Tj
3.6793 0 Td
(and)Tj
1.7688 0 Td
(I)Tj
0.5726 0 Td
(6364)Tj
2.7043 0 Td
(\(2)Tj
1.0658 0 Td
(points\),)Tj
3.3845 0 Td
(TIA)Tj
1.8936 0 Td
(435)Tj
1.6894 0 Td
(and)Tj
1.7688 0 Td
(G)Tj
0.9468 0 Td
(45)Tj
1.1962 0 Td
(\(2)Tj
1.0658 0 Td
(points\))Tj
3.1465 0 Td
(and)Tj
1.7688 0 Td
(vascu-)Tj
-34.4804 -1.2982 Td
(lar)Tj
1.3095 0 Td
(disease)Tj
3.1068 0 Td
(410414,)Tj
3.9231 0 Td
(440,)Tj
1.9219 0 Td
(443.9)Tj
2.4151 0 Td
(and)Tj
1.7688 0 Td
(I)Tj
0.5726 0 Td
(2025,)Tj
2.9424 0 Td
(I)Tj
0.5725 0 Td
(70,)Tj
1.44 0 Td
(I)Tj
0.5726 0 Td
(73.9)Tj
1.9219 0 Td
(\(1)Tj
1.0602 0 Td
(point\))Tj
2.7779 0 Td
(from)Tj
2.2564 0 Td
(1987)Tj
2.177 0 Td
(and)Tj
1.7688 0 Td
(until)Tj
2.1713 0 Td
(30)Tj
-34.6788 -1.2983 Td
(days)Tj
2.0466 0 Td
(after)Tj
2.1032 0 Td
(the)Tj
1.5081 0 Td
(date)Tj
1.9559 0 Td
(of)Tj
1.0374 0 Td
(diagnosis)Tj
4.0762 0 Td
(of)Tj
1.0432 0 Td
(incident)Tj
3.6283 0 Td
(AF.)Tj
1.6951 0 Td
(The)Tj
1.8198 0 Td
(educational)Tj
5.0003 0 Td
(background)Tj
5.159 0 Td
(was)Tj
1.7405 0 Td
(obtained)Tj
-32.8136 -1.2983 Td
(from)Tj
2.2563 0 Td
(the)Tj
1.508 0 Td
(Swedish)Tj
3.5773 0 Td
(Register)Tj
3.5547 0 Td
(of)Tj
1.0431 0 Td
(Education)Tj
4.439 0 Td
(and)Tj
1.7688 0 Td
(the)Tj
1.5081 0 Td
(Population)Tj
4.7621 0 Td
(and)Tj
1.7745 0 Td
(Housing)Tj
3.7531 0 Td
(Census)Tj
3.1804 0 Td
(Registry)Tj
-33.1254 -1.3039 Td
(by)Tj
1.2075 0 Td
(Statistics)Tj
3.8324 0 Td
(Sweden.)Tj
-0.004 Tc
-3.8437 -1.2982 Td
(Warfarin)Tj
3.9004 0 Td
(was)Tj
1.7008 0 Td
(the)Tj
1.4683 0 Td
(only)Tj
1.9786 0 Td
(registered)Tj
4.1499 0 Td
(oral)Tj
1.7801 0 Td
(anticoagulant)Tj
5.6523 0 Td
(in)Tj
1.0375 0 Td
(Sweden)Tj
3.2995 0 Td
(during)Tj
2.931 0 Td
(our)Tj
1.627 0 Td
(study)Tj
2.3868 0 Td
(period,)Tj
-33.1084 -1.2983 Td
(and)Tj
1.7291 0 Td
(phenprocoumon)Tj
6.9675 0 Td
(could)Tj
2.4491 0 Td
(be)Tj
1.1509 0 Td
(prescribed)Tj
4.4163 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(].)Tj
1.5987 0 Td
(During)Tj
3.1351 0 Td
(the)Tj
1.4684 0 Td
(years)Tj
2.2677 0 Td
(of)Tj
1.0148 0 Td
(this)Tj
1.6724 0 Td
(study,)Tj
2.6135 0 Td
(acetylsalicylic)Tj
-30.4835 -1.3039 Td
(acid)Tj
1.8708 0 Td
(\(ASA\))Tj
2.7439 0 Td
(was)Tj
1.7008 0 Td
(recommended)Tj
6.0321 0 Td
(for)Tj
1.389 0 Td
(patients)Tj
3.3675 0 Td
(with)Tj
1.9956 0 Td
(0)Tj
0.6973 0 Td
(and)Tj
1.7291 0 Td
(1)Tj
0.6973 0 Td
(point)Tj
2.3584 0 Td
(based)Tj
2.4718 0 Td
(on)Tj
1.2756 0 Td
(the)Tj
1.4684 0 Td
(CHADS)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 531.2692 601.7385 cm
BT
/F8 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 537.0519 603.3826 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(score)Tj
2.3017 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(].)Tj
-36.0054 -1.2982 Td
(Recent)Tj
2.9594 0 Td
(studies)Tj
2.982 0 Td
(do)Tj
1.2586 0 Td
(not)Tj
1.5704 0 Td
(support)Tj
3.3221 0 Td
(ASA)Tj
2.0637 0 Td
(in)Tj
1.0374 0 Td
(patients)Tj
3.3676 0 Td
(with)Tj
1.9955 0 Td
(AF,)Tj
1.6555 0 Td
(and)Tj
1.7348 0 Td
(current)Tj
3.1804 0 Td
(guidelines)Tj
4.2803 0 Td
(do)Tj
1.2529 0 Td
(not)Tj
1.576 0 Td
(recom-)Tj
-34.2366 -1.2983 Td
(mend)Tj
2.5399 0 Td
(it)Tj
0.7823 0 Td
(for)Tj
1.389 0 Td
(protection)Tj
4.3823 0 Td
(of)Tj
1.0148 0 Td
(cerebral)Tj
3.4186 0 Td
(infarction;)Tj
4.3993 0 Td
(we)Tj
1.3266 0 Td
(therefore)Tj
3.8551 0 Td
(did)Tj
1.542 0 Td
(not)Tj
1.5761 0 Td
(consider)Tj
3.6453 0 Td
(ASA)Tj
2.0636 0 Td
(to)Tj
1.0262 0 Td
(be)Tj
1.1507 0 Td
(analyzed)Tj
-34.1118 -1.3039 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(15)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
(16)Tj
0 g
(].)Tj
1.1962 -1.2983 Td
(In)Tj
1.1112 0 Td
(Sweden,)Tj
3.5263 0 Td
(all)Tj
1.1508 0 Td
(inhabitants)Tj
4.7112 0 Td
(have)Tj
2.0579 0 Td
(a)Tj
0.652 0 Td
(unique)Tj
3.0217 0 Td
(personal)Tj
3.6283 0 Td
(identification)Tj
5.5899 0 Td
(number,)Tj
3.6397 0 Td
(all)Tj
1.1508 0 Td
(have)Tj
2.058 0 Td
(equal)Tj
-33.494 -1.2982 Td
(access)Tj
2.6476 0 Td
(to)Tj
1.0204 0 Td
(health)Tj
2.6816 0 Td
(care)Tj
1.8708 0 Td
(and)Tj
1.7292 0 Td
(hospital)Tj
3.3788 0 Td
(services,)Tj
3.532 0 Td
(and)Tj
1.7291 0 Td
(hospitals)Tj
3.7417 0 Td
(are)Tj
1.4457 0 Td
(required)Tj
3.6396 0 Td
(to)Tj
1.0262 0 Td
(record)Tj
2.8459 0 Td
(all)Tj
1.1452 0 Td
(discharge)Tj
-32.4338 -1.3039 Td
(diagnoses.)Tj
4.337 0 Td
(This)Tj
1.9899 0 Td
(provides)Tj
3.651 0 Td
(the)Tj
1.4684 0 Td
(possibility)Tj
4.2746 0 Td
(to)Tj
1.0204 0 Td
(record)Tj
2.846 0 Td
(and)Tj
1.7291 0 Td
(track)Tj
2.2451 0 Td
(all)Tj
1.1451 0 Td
(non-emigrated)Tj
6.2079 0 Td
(patients)Tj
3.3674 0 Td
(in)Tj
1.0375 0 Td
(clini-)Tj
-35.3194 -1.2983 Td
(cal)Tj
1.321 0 Td
(registries)Tj
3.8324 0 Td
(and)Tj
1.7291 0 Td
(examine)Tj
3.6 0 Td
(morbidity)Tj
4.2406 0 Td
(and)Tj
1.7291 0 Td
(mortality)Tj
3.9175 0 Td
(in)Tj
1.0374 0 Td
(the)Tj
1.4684 0 Td
(entire)Tj
2.5511 0 Td
(Swedish)Tj
3.4866 0 Td
(population.)Tj
4.8188 0 Td
(This)Tj
-33.732 -1.2983 Td
(study)Tj
2.3868 0 Td
(complied)Tj
3.9515 0 Td
(with)Tj
2.0012 0 Td
(the)Tj
1.4683 0 Td
(Declaration)Tj
4.9096 0 Td
(of)Tj
1.0148 0 Td
(Helsinki,)Tj
3.8211 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.474 0 Td
(study)Tj
2.3868 0 Td
(protocol)Tj
3.6 0 Td
(was)Tj
1.6951 0 Td
(approved)Tj
3.974 0 Td
(by)Tj
1.1849 0 Td
(the)Tj
-35.5972 -1.2982 Td
(Regional)Tj
3.7304 0 Td
(Ethical)Tj
2.9877 0 Td
(Review)Tj
3.0954 0 Td
(Board)Tj
2.6362 0 Td
(in)Tj
1.0375 0 Td
(Uppsala,)Tj
3.6907 0 Td
(Sweden)Tj
3.3051 0 Td
(\(Dnr)Tj
2.2167 0 Td
(2009/273\).)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 455.6409 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Study)Tj
2.7543 0 Td
(cohort)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 438.633 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(In)Tj
1.1055 0 Td
(total,)Tj
2.2336 0 Td
(there)Tj
2.2621 0 Td
(were)Tj
2.1203 0 Td
(272)Tj
1.6497 0 Td
(186)Tj
1.6441 0 Td
(patients)Tj
3.3676 0 Td
(with)Tj
2.0012 0 Td
(incident)Tj
3.5206 0 Td
(AF)Tj
1.4343 0 Td
(between)Tj
3.5263 0 Td
(1987)Tj
2.126 0 Td
(and)Tj
1.7291 0 Td
(2008)Tj
2.1203 0 Td
(and,)Tj
1.9559 0 Td
(of)Tj
1.0148 0 Td
(those,)Tj
2.5625 0 Td
(59)Tj
-36.3739 -1.2982 Td
(981)Tj
1.644 0 Td
(had)Tj
1.7121 0 Td
(a)Tj
0.652 0 Td
(diagnosis)Tj
3.9572 0 Td
(of)Tj
1.0148 0 Td
(AF)Tj
1.4343 0 Td
(during)Tj
2.9253 0 Td
(the)Tj
1.474 0 Td
(inclusion)Tj
3.9118 0 Td
(period)Tj
2.8346 0 Td
(between)Tj
3.532 0 Td
(1)Tj
0.6916 0 Td
(January)Tj
3.3222 0 Td
(2006)Tj
2.1203 0 Td
(and)Tj
1.7348 0 Td
(31)Tj
1.1679 0 Td
(Decem-)Tj
-34.1289 -1.2983 Td
(ber)Tj
1.5193 0 Td
(2008)Tj
2.126 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(Fig)Tj
1.8198 0 Td
(1)Tj
0 g
(\).)Tj
1.2586 0 Td
(We)Tj
1.6101 0 Td
(excluded)Tj
3.787 0 Td
(11)Tj
1.1679 0 Td
(548)Tj
1.6497 0 Td
(patients)Tj
3.3676 0 Td
(who)Tj
1.9389 0 Td
(had)Tj
1.7064 0 Td
(warfarin)Tj
3.6227 0 Td
(before)Tj
2.7382 0 Td
(the)Tj
1.4683 0 Td
(diagnosis)Tj
3.9572 0 Td
(of)Tj
1.0148 0 Td
(AF)Tj
1.4343 0 Td
(or)Tj
-36.1868 -1.3039 Td
(had)Tj
1.7064 0 Td
(died,)Tj
2.194 0 Td
(emigrated)Tj
4.2519 0 Td
(or)Tj
1.0942 0 Td
(suffered)Tj
3.4299 0 Td
(a)Tj
0.6576 0 Td
(stroke)Tj
2.6759 0 Td
(within)Tj
2.812 0 Td
(30)Tj
1.1735 0 Td
(days)Tj
1.9956 0 Td
(after)Tj
2.0353 0 Td
(diagnosis.)Tj
4.1839 0 Td
(The)Tj
1.7858 0 Td
(remaining)Tj
4.3596 0 Td
(48)Tj
1.1736 0 Td
(433)Tj
-35.5292 -1.2983 Td
(patients)Tj
3.3675 0 Td
(were)Tj
2.1203 0 Td
(categorized)Tj
4.7735 0 Td
(into)Tj
1.8425 0 Td
(three)Tj
2.2677 0 Td
(groups:)Tj
3.1918 0 Td
(1\))Tj
1.0375 0 Td
(warfarin)Tj
3.617 0 Td
(treatment)Tj
4.1329 0 Td
(started)Tj
2.9366 0 Td
(within)Tj
2.812 0 Td
(30)Tj
1.1735 0 Td
(days)Tj
1.9956 0 Td
(and)Tj
-35.2684 -1.2982 Td
(regular)Tj
3.0557 0 Td
(withdrawal,)Tj
4.9209 0 Td
(2\))Tj
1.0375 0 Td
(no)Tj
1.2755 0 Td
(warfarin)Tj
3.617 0 Td
(and)Tj
1.7292 0 Td
(3\))Tj
1.0374 0 Td
(warfarin)Tj
3.617 0 Td
(treatment)Tj
4.1386 0 Td
(started)Tj
2.931 0 Td
(after)Tj
2.0352 0 Td
(30)Tj
1.1736 0 Td
(days)Tj
1.9956 0 Td
(or)Tj
1.0998 0 Td
(more)Tj
2.3414 0 Td
(or)Tj
-36.0054 -1.3039 Td
(irregular)Tj
3.6963 0 Td
(withdrawal.)Tj
4.9209 0 Td
(These)Tj
2.5682 0 Td
(groups)Tj
2.965 0 Td
(consisted)Tj
3.9401 0 Td
(of)Tj
1.0148 0 Td
(15)Tj
1.1736 0 Td
(782,)Tj
1.8708 0 Td
(27)Tj
1.1679 0 Td
(166)Tj
1.6498 0 Td
(and)Tj
1.7291 0 Td
(5)Tj
0.6973 0 Td
(485)Tj
1.6441 0 Td
(patients,)Tj
3.5943 0 Td
(respectively)Tj
-32.6322 -1.2983 Td
(\()Tj
0.83 0.64 0.02 0 k
(Table)Tj
2.7779 0 Td
(1)Tj
0 g
(\).)Tj
1.2642 0 Td
(Our)Tj
1.8652 0 Td
(definition)Tj
4.1612 0 Td
(of)Tj
1.0148 0 Td
(regular)Tj
3.0614 0 Td
(withdrawal)Tj
4.6942 0 Td
(was)Tj
1.7008 0 Td
(that)Tj
1.7744 0 Td
(warfarin)Tj
3.6227 0 Td
(had)Tj
1.7064 0 Td
(been)Tj
2.126 0 Td
(collected)Tj
3.7361 0 Td
(at)Tj
0.9524 0 Td
(a)Tj
0.652 0 Td
(phar-)Tj
-35.1097 -1.2983 Td
(macy)Tj
2.3527 0 Td
(at)Tj
0.9524 0 Td
(least)Tj
1.9786 0 Td
(once)Tj
2.126 0 Td
(a)Tj
0.6519 0 Td
(year)Tj
1.9049 0 Td
(after)Tj
2.0353 0 Td
(the)Tj
1.4683 0 Td
(date)Tj
1.9049 0 Td
(of)Tj
1.0148 0 Td
(incident)Tj
3.5262 0 Td
(AF.)Tj
1.6555 0 Td
(Over-)Tj
2.5681 0 Td
(and)Tj
1.7292 0 Td
(under-treatment)Tj
6.8824 0 Td
(are)Tj
1.4514 0 Td
(well)Tj
-34.2026 -1.3039 Td
(known,)Tj
3.2314 0 Td
(and)Tj
1.7291 0 Td
(some)Tj
2.3301 0 Td
(patients)Tj
3.3676 0 Td
(were)Tj
2.1203 0 Td
(treated)Tj
2.999 0 Td
(regularly)Tj
3.7587 0 Td
(with)Tj
2.0013 0 Td
(warfarin)Tj
3.6169 0 Td
(contrary)Tj
3.6284 0 Td
(to)Tj
1.0261 0 Td
(contemporary)Tj
-29.8089 -1.2983 Td
(guidelines)Tj
4.2746 0 Td
([)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
(].)Tj
2.0806 0 Td
(Although)Tj
4.0025 0 Td
(treatment)Tj
4.1329 0 Td
(should)Tj
2.9196 0 Td
(be)Tj
1.1509 0 Td
(started)Tj
2.931 0 Td
(instantly)Tj
3.6793 0 Td
(when)Tj
2.4038 0 Td
(the)Tj
1.4683 0 Td
(indication)Tj
4.3087 0 Td
(is)Tj
0.8504 0 Td
(clear,)Tj
-34.2026 -1.2982 Td
(we)Tj
1.3266 0 Td
(applied)Tj
3.1521 0 Td
(a)Tj
0.6519 0 Td
(cut-off)Tj
2.9084 0 Td
(at)Tj
0.9467 0 Td
(30)Tj
1.1736 0 Td
(days)Tj
1.9955 0 Td
(so)Tj
1.0885 0 Td
(that)Tj
1.7802 0 Td
(the)Tj
1.4683 0 Td
(necessary)Tj
4.0195 0 Td
(diagnostics,)Tj
4.9096 0 Td
(for)Tj
1.3833 0 Td
(example)Tj
3.5489 0 Td
(echocardiography)Tj
-30.3531 -1.3039 Td
(or)Tj
1.0941 0 Td
(newly)Tj
2.5795 0 Td
(discovered)Tj
4.5071 0 Td
(diabetes)Tj
3.4639 0 Td
(mellitus,)Tj
3.634 0 Td
(were)Tj
2.1203 0 Td
(completed)Tj
4.4107 0 Td
(to)Tj
1.0204 0 Td
(determine)Tj
4.3257 0 Td
(the)Tj
1.4683 0 Td
(CHA)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 507.4015 280.97 cm
BT
/F8 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 510.9732 282.6141 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(DS)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 523.1055 280.97 cm
BT
/F8 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 526.6771 282.6141 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(-VASc)Tj
-32.6662 -1.2982 Td
(score.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 238.9039 cm
BT
/F0 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Time-varying)Tj
5.9339 0 Td
(exposure)Tj
4.285 0 Td
(analysis)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 221.896 cm
BT
/F8 1 Tf
1 TL
-0.004 Tc
0 0 Td
(To)Tj
1.3379 0 Td
(include)Tj
3.1804 0 Td
(all)Tj
1.1509 0 Td
(eligible)Tj
3.0614 0 Td
(patients)Tj
3.3732 0 Td
(and)Tj
1.7291 0 Td
(to)Tj
1.0262 0 Td
(decrease)Tj
3.6056 0 Td
(the)Tj
1.4684 0 Td
(risk)Tj
1.7177 0 Td
(of)Tj
1.0148 0 Td
(treatment)Tj
4.1329 0 Td
(misclassification,)Tj
7.0242 0 Td
(we)Tj
1.3266 0 Td
(used)Tj
-35.1493 -1.3039 Td
(time-varying)Tj
5.3744 0 Td
(exposure)Tj
3.8154 0 Td
(analysis.)Tj
3.5546 0 Td
(This)Tj
1.9843 0 Td
(means)Tj
2.8063 0 Td
(that)Tj
1.7801 0 Td
(patients)Tj
3.3675 0 Td
(with)Tj
1.9956 0 Td
(irregular)Tj
3.6964 0 Td
(warfarin)Tj
3.6226 0 Td
(treatment)Tj
4.1329 0 Td
(or)Tj
-36.1301 -1.2982 Td
(who)Tj
1.9388 0 Td
(had)Tj
1.7065 0 Td
(started)Tj
2.9367 0 Td
(warfarin)Tj
3.6169 0 Td
(after)Tj
2.0353 0 Td
(30)Tj
1.1735 0 Td
(days)Tj
1.9956 0 Td
(or)Tj
1.0999 0 Td
(more)Tj
2.3414 0 Td
(from)Tj
2.2053 0 Td
(incident)Tj
3.5206 0 Td
(AF)Tj
1.4343 0 Td
(are)Tj
1.4514 0 Td
(included)Tj
3.7076 0 Td
(in)Tj
1.0375 0 Td
(both)Tj
2.058 0 Td
(the)Tj
-34.2593 -1.2983 Td
(exposed)Tj
3.4412 0 Td
(and)Tj
1.7348 0 Td
(non-exposed)Tj
5.3971 0 Td
(arms)Tj
2.2054 0 Td
(at)Tj
0.9524 0 Td
(different)Tj
3.6567 0 Td
(times)Tj
2.3924 0 Td
(depending)Tj
4.4674 0 Td
(on)Tj
1.2755 0 Td
(whether)Tj
3.4753 0 Td
(warfarin)Tj
3.617 0 Td
(treatment)Tj
4.1385 0 Td
(is)Tj
-36.7537 -1.2983 Td
(on-going)Tj
3.8777 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(Table)Tj
2.7836 0 Td
(2)Tj
0 g
(\).)Tj
1.2586 0 Td
(Patients)Tj
3.4129 0 Td
(with)Tj
1.9956 0 Td
(warfarin)Tj
3.617 0 Td
(treatment)Tj
4.1385 0 Td
(started)Tj
2.931 0 Td
(within)Tj
2.812 0 Td
(30)Tj
1.1735 0 Td
(days)Tj
1.9956 0 Td
(of)Tj
1.0148 0 Td
(incident)Tj
3.5263 0 Td
(AF)Tj
-34.5371 -1.3039 Td
(were)Tj
2.1203 0 Td
(analyzed)Tj
3.702 0 Td
(in)Tj
1.0374 0 Td
(the)Tj
1.4684 0 Td
(exposed)Tj
3.4469 0 Td
(arm)Tj
1.8425 0 Td
(and)Tj
1.7291 0 Td
(those)Tj
2.3414 0 Td
(without)Tj
3.3279 0 Td
(warfarin)Tj
3.617 0 Td
(in)Tj
1.0374 0 Td
(the)Tj
1.4684 0 Td
(non-exposed)Tj
5.4028 0 Td
(arm)Tj
1.8425 0 Td
(during)Tj
-34.384 -1.2982 Td
(the)Tj
1.4683 0 Td
(study)Tj
2.3867 0 Td
(period)Tj
2.8347 0 Td
(or)Tj
1.0998 0 Td
(until)Tj
2.109 0 Td
(an)Tj
1.2019 0 Td
(endpoint.)Tj
-9.9042 -1.2983 Td
(In)Tj
1.1111 0 Td
(the)Tj
1.4684 0 Td
(time-varying)Tj
5.3744 0 Td
(analysis,)Tj
3.5547 0 Td
(patients)Tj
3.3675 0 Td
(with)Tj
1.9956 0 Td
(warfarin)Tj
3.617 0 Td
(with)Tj
2.0012 0 Td
(irregular)Tj
3.6964 0 Td
(withdrawal)Tj
4.6941 0 Td
(or)Tj
1.0998 0 Td
(who)Tj
-33.1764 -1.3039 Td
(started)Tj
2.931 0 Td
(after)Tj
2.0352 0 Td
(30)Tj
1.1736 0 Td
(days)Tj
1.9955 0 Td
(or)Tj
1.0999 0 Td
(more)Tj
2.3414 0 Td
(are)Tj
1.4456 0 Td
(included)Tj
3.7134 0 Td
(in)Tj
1.0375 0 Td
(the)Tj
1.4683 0 Td
(exposed)Tj
3.4469 0 Td
(or)Tj
1.0998 0 Td
(non-exposed)Tj
5.3972 0 Td
(arms)Tj
2.2053 0 Td
(at)Tj
0.9525 0 Td
(different)Tj
-32.3431 -1.2983 Td
(times)Tj
2.3867 0 Td
(depending)Tj
4.473 0 Td
(on)Tj
1.2756 0 Td
(whether)Tj
3.4753 0 Td
(warfarin)Tj
3.617 0 Td
(treatment)Tj
4.1385 0 Td
(was)Tj
1.6951 0 Td
(on-going.)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 259.0866 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Atrial)Tj
2.459 0 Td
(fibrillation)Tj
4.3442 0 Td
(and)Tj
1.8567 0 Td
(an)Tj
1.3039 0 Td
(age)Tj
1.8567 0 Td
(of)Tj
1.0418 0 Td
(65)Tj
1.311 0 Td
(years)Tj
2.6291 0 Td
(and)Tj
1.8497 0 Td
(older)Tj
2.4023 0 Td
(-)Tj
0.5457 0 Td
(Enough)Tj
3.6071 0 Td
(to)Tj
1.0418 0 Td
(justify)Tj
2.7283 0 Td
(anticoagu)Tj
4.252 0 Td
(lation)Tj
2.5583 0 Td
(therapy?)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01768)Tj
4.089 0 Td
(46)Tj
0 g
2.0906 0 Td
(May)Tj
2.0906 0 Td
(4,)Tj
1.0346 0 Td
(2017)Tj
35.7806 0 Td
(3)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
58 0 obj
<>stream
endstream
endobj
59 0 obj
<>stream
endstream
endobj
60 0 obj
<>stream
endstream
endobj
61 0 obj
<>stream
endstream
endobj
62 0 obj
<>stream
endstream
endobj
63 0 obj
<>stream
endstream
endobj
64 0 obj
<>stream
endstream
endobj
65 0 obj
<>stream
endstream
endobj
66 0 obj
<>stream
endstream
endobj
67 0 obj
<>stream
endstream
endobj
68 0 obj
<>stream
BT
66.402 0 Td
(17)Tj
ET
Q
endstream
endobj
69 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 13 0 R/Annots 71 0 R/Contents 72 0 R/TrimBox[0 0 612 792]>>
endobj
70 0 obj
<>stream
x?